CytoMed Therapeutics Limited Shortterm Employee Benefits Expense
CytoMed Therapeutics Limited (GDTC) reported Shortterm Employee Benefits Expense of SGD 1.79 million for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-31.
Financial Statements › Expense Statement › Operating Expenses
ifrs-full:ShorttermEmployeeBenefitsExpense · last filed 2026-03-31
| Period end | Shortterm Employee Benefits Expense 12 month |
|---|---|
| 2025-12-31 | 1.79M SGD 20-F · filed 2026-03-31 |
| 2024-12-31 | 1.36M SGD 20-F · filed 2026-03-31 |
| 2023-12-31 | 1.10M SGD 20-F · filed 2026-03-31 |
| 2022-12-31 | 710.70K SGD 20-F · filed 2025-04-28 |
| 2021-12-31 | 569.05K SGD 20-F · filed 2024-04-22 |
| 2020-12-31 | 473.83K SGD 20-F · filed 2023-05-01 |